XML 22 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating activities:    
Net loss $ (2,111,658) $ (3,440,105)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 673,203 639,026
Depreciation-Right of Use Assets - Financing 18,649 30,642
Stock based compensation 396,312 432,084
Grant expense (5,000) 5,000
Amortization of financing fees 833 2,083
Adjustment to expected losses on accounts receivable (1,100,000) (38,875)
Gain on marketable securities 0 (14,418)
Stock warrant expense 0 (9,874)
Change in operating assets and liabilities:    
Accounts receivable 1,616,597 2,037,941
Referral and support services agreement advance 75,000 75,000
Prepaid expenses, unbilled revenue and other current assets 57,245 (171,434)
Accrued expenses and other liabilities 124,540 (240,104)
Accounts payable (1,101,313) (2,537,965)
Net cash used in operating activities (1,355,592) (3,230,999)
Investing activities:    
Purchases of equipment and capitalized development costs (472,228) (411,238)
Proceeds from the sale of marketable securities   2,288,876
Net cash provided by/(used in) investing activities (472,228) 1,877,638
Financing activities:    
Net proceeds from line of credit 0 592,868
Payments on finance lease obligations (18,705) (34,467)
Net taxes paid on restricted stock unit grants exercised (161,972) (166,872)
Net cash provided by/(used in) financing activities (180,677) 391,529
Net change - cash (2,008,497) (961,832)
Cash and cash equivalent, beginning of year 4,440,454 2,931,415
Cash and cash equivalent, end of period 2,431,957 1,969,583
Supplemental information:    
Interest paid 36,914 29,953
Acquisition of right of use asset for operating lease liability $ 335,286 $ 0